Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
sacituzumab govitecan
×
Thoracic
×
Clear all
Filters
3
NCT05609968
2025-12-24
MK-3475-D46
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
614 enrolled
NCT05089734
2025-05-23
EVOKE-01
Gilead Sciences
Phase 3
Active not recruiting
603 enrolled
20 charts
NCT06431633
2025-04-10
ARIAN
Fundación GECP
Phase 3
Recruiting
129 enrolled